Wuhan Hvsen Biotechnology Stock Debt To Equity
| 300871 Stock | 11.40 0.01 0.09% |
Wuhan Hvsen Biotechnology fundamentals help investors to digest information that contributes to Wuhan Hvsen's financial success or failures. It also enables traders to predict the movement of Wuhan Stock. The fundamental analysis module provides a way to measure Wuhan Hvsen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Wuhan Hvsen stock.
Wuhan | Debt To Equity |
Wuhan Hvsen Biotechnology Company Debt To Equity Analysis
Wuhan Hvsen's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
Wuhan Other Stockholder Equity
Other Stockholder Equity |
|
According to the company disclosure, Wuhan Hvsen Biotechnology has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The debt to equity for all China stocks is 100.0% higher than that of the company.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Wuhan Fundamentals
| Return On Equity | -0.0312 | ||||
| Return On Asset | -0.0029 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 2.33 B | ||||
| Shares Outstanding | 165.77 M | ||||
| Shares Owned By Insiders | 60.51 % | ||||
| Shares Owned By Institutions | 3.84 % | ||||
| Price To Book | 1.33 X | ||||
| Price To Sales | 1.69 X | ||||
| Revenue | 1.02 B | ||||
| Gross Profit | 222.75 M | ||||
| EBITDA | 150.08 M | ||||
| Net Income | 16.78 M | ||||
| Total Debt | 240.32 M | ||||
| Book Value Per Share | 8.62 X | ||||
| Cash Flow From Operations | 92.92 M | ||||
| Earnings Per Share | (0.28) X | ||||
| Target Price | 17.89 | ||||
| Number Of Employees | 1.07 K | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 1.89 B | ||||
| Total Asset | 2.98 B | ||||
| Retained Earnings | 341.94 M | ||||
| Working Capital | 484.9 M | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 2.98 B | ||||
| Last Dividend Paid | 0.27 |
About Wuhan Hvsen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Wuhan Hvsen Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wuhan Hvsen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wuhan Hvsen Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Wuhan Stock
Wuhan Hvsen financial ratios help investors to determine whether Wuhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wuhan with respect to the benefits of owning Wuhan Hvsen security.